1,140
Views
29
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Synergistic antitumor activity of XIAP-shRNA and TRAIL expressed by oncolytic adenoviruses in experimental HCC

, , , , &
Pages 135-144 | Received 22 Dec 2006, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Ming Yang, Chun Sheng Yang, WenWen Guo, JianQin Tang, Qian Huang, ShouXin Feng, AiJun Jiang, XiFeng Xu, Guan Jiang & Yan Qun Liu. (2017) A novel fiber chimeric conditionally replicative adenovirus-Ad5/F35 for tumor therapy. Cancer Biology & Therapy 18:11, pages 833-840.
Read now
Luc JW van der Laan, Yigang Wang, Hugo W Tilanus, Harry LA Janssen & Qiuwei Pan. (2011) AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?. Expert Opinion on Biological Therapy 11:3, pages 315-327.
Read now
Dong-Sheng Pei, Jie-Hui Di, Fei-Fei Chen & Jun-Nian Zheng. (2010) Oncolytic-adenovirus-expressed RNA interference for cancer therapy. Expert Opinion on Biological Therapy 10:9, pages 1331-1341.
Read now
Yi Lu & Chikezie O Madu. (2010) Viral-based gene delivery and regulated gene expression for targeted cancer therapy. Expert Opinion on Drug Delivery 7:1, pages 19-35.
Read now
Shou-Li Wang, Hui-Hua Yao & Zheng-Hong Qin. (2009) Strategies for short hairpin RNA delivery in cancer gene therapy. Expert Opinion on Biological Therapy 9:11, pages 1357-1368.
Read now

Articles from other publishers (24)

Xiao-xia Ma, Zhongren Ma & Qiuwei Pan. (2018) The Challenges of Long-Term Transcriptional Gene Silencing by RNA Viruses. Trends in Biochemical Sciences 43:9, pages 649-650.
Crossref
Ding WeiJing XuXin-Yuan LiuZhi-Nan ChenHuijie Bian. (2018) Fighting Cancer with Viruses: Oncolytic Virus Therapy in China. Human Gene Therapy 29:2, pages 151-159.
Crossref
Guoying Zhang, Zheng Li, Xiaochun Wan, Ying Zhang, Rongqin Zhu, Zhenzhen Liu, Dexin Ji, Huarong Zhang, Fei Wu, Huihui Tian, Kun Liu & Benhao Wu. (2016) Repression of Human Hepatocellular Carcinoma Growth by Regulating Met/EGFR/VEGFR-Akt/NF-κB Pathways with Theanine and Its Derivative, ( R )-2-(6,8-Dibromo-2-oxo-2 H -chromene-3-carboxamido)-5-(ethylamino)-5-oxopentanoic Ethyl Ester (DTBrC) . Journal of Agricultural and Food Chemistry 64:37, pages 7002-7013.
Crossref
R Zhang, X Zhang, B Ma, B Xiao, F Huang, P Huang, C Ying, T Liu & Y Wang. (2016) Enhanced antitumor effect of combining TRAIL and MnSOD mediated by CEA-controlled oncolytic adenovirus in lung cancer. Cancer Gene Therapy 23:6, pages 168-177.
Crossref
Jie Zhang, Meng Ding, Kai Xu, Lijun Mao & Junian Zheng. (2016) shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy. Oncotarget 7:20, pages 29824-29834.
Crossref
Kai Li, Xinhong Li, Zhongjun Wu, Liansheng Zheng, Yuqin Cui, Jun Wang, Yin Huang & Zhihong Yan. (2016) Adenovirus encoding XAF-1 and TNF‑α in the same open reading frame efficiently inhibits hepatocellular cancer cells. Molecular Medicine Reports.
Crossref
Yi-Gang Wang. (2016) Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma. World Journal of Gastroenterology 22:1, pages 326.
Crossref
P Y Hernanda, K Chen, A M Das, K Sideras, W Wang, J Li, W Cao, S J A Bots, L L Kodach, R A de Man, J N M Ijzermans, H L A Janssen, A P Stubbs, D Sprengers, M J Bruno, H J Metselaar, T L M ten Hagen, J Kwekkeboom, M P Peppelenbosch & Q Pan. (2014) SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma. Oncogene 34:39, pages 5055-5068.
Crossref
Adel H. Jebar, Richard G. Vile, Alan A. Melcher, Stephen Griffin, Peter J. Selby & Fiona Errington-Mais. (2015) Progress in clinical oncolytic virus-based therapy for hepatocellular carcinoma. Journal of General Virology 96:7, pages 1533-1550.
Crossref
HONG ZHANG, ZHIHONG LI, KAIZHONG WANG & PING REN. (2015) Combined treatment of XIAP-targeting shRNA and celecoxib synergistically inhibits the tumor growth of non-small cell lung cancer cells in vitro and in vivo. Oncology Reports 33:3, pages 1079-1088.
Crossref
A?elya Yilmazer, Bowen Tian & Kostas Kostarelos. (2014) Development of Dual-Activity Vectors by Co-Envelopment of Adenovirus and SiRNA in Artificial Lipid Bilayers. PLoS ONE 9:12, pages e114985.
Crossref
Li Ming Zhu, Dong Mei Shi, Qiang Dai, Xiao Jiao Cheng, Wei Yan Yao, Ping Hu Sun, Yan Fei Ding, Min Min Qiao, Yun Lin Wu, Shi Hu Jiang & Shui Ping Tu. (2014) Tumor suppressor XAF1 induces apoptosis, inhibits angiogenesis and inhibits tumor growth in hepatocellular carcinoma. Oncotarget 5:14, pages 5403-5415.
Crossref
Pratika Y. Hernanda, Alexander Pedroza-Gonzalez, Luc J.W. van der Laan, Mirelle E.E. Br?ker, Martin J. Hoogduijn, Jan N.M. Ijzermans, Marco J. Bruno, Harry L.A. Janssen, Maikel P. Peppelenbosch & Qiuwei Pan. (2013) Tumor promotion through the mesenchymal stem cell compartment in human hepatocellular carcinoma. Carcinogenesis 34:10, pages 2330-2340.
Crossref
Chae-Ok Yun. 2013. Advanced Delivery and Therapeutic Applications of RNAi. Advanced Delivery and Therapeutic Applications of RNAi 309 326 .
Shuijun Zhang, Gongquan Li, Yongfu Zhao, Guangzhi Liu, Yu Wang, Xiuxian Ma, Dexu Li, Yang Wu & Jianfeng Lu. (2012) Smac Mimetic SM-164 Potentiates APO2L/TRAIL- and Doxorubicin-Mediated Anticancer Activity in Human Hepatocellular Carcinoma Cells. PLoS ONE 7:12, pages e51461.
Crossref
Venturina Stagni, Simonetta Santini & Daniela Barilà. (2012) A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase. Cancers 4:2, pages 354-378.
Crossref
Liu Xin-Yuan, Wen-Lin Huang, Qi-Jun Qian, Wei-Guo Zou, Zi-Lai Zhang, Liang Chu, Kang-Jian Zhang, Li-Li Zhao, Yan-Hong Zhang, Song-Bo Qiu, Zhen-Wei Zhang, Tian Xiao, Jun-Kai Fan, Na Wei, Xin-Ran Liu, Xin Cao, Jin-Fa Gu, Rui-Cheng Wei, Miao Ding & Shuai Wu. 2012. Recent Advances in Cancer Research and Therapy. Recent Advances in Cancer Research and Therapy 33 83 .
Henry Fechner & Jens Kurreck. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology 1415 1442 .
G. Gonzalez-Aseguinolaza, J. Prieto & R. Hernandez-Alcoceba. (2011) Gene therapy of liver cancer: an updateThérapie génique du cancer du foie : le point. Journal Africain du Cancer / African Journal of Cancer 3:3, pages 180-192.
Crossref
Guan Jiang, Yong Xin, Jun‐Nian Zheng & Yan‐Qun Liu. (2011) Combining conditionally replicating adenovirus‐mediated gene therapy with chemotherapy: A novel antitumor approach. International Journal of Cancer 129:2, pages 263-274.
Crossref
R M Eager & J Nemunaitis. (2011) Clinical development directions in oncolytic viral therapy. Cancer Gene Therapy 18:5, pages 305-317.
Crossref
Qing Chen, Wenjia Lou, Junjie Shen, Leina Ma, Zhi Yang, Li Liu, Jingjing Luo & Cheng Qian. (2010) Potent Antitumor Activity in Experimental Hepatocellular Carcinoma by Adenovirus-Mediated Coexpression of TRAIL and shRNA against COX-2 . Clinical Cancer Research 16:14, pages 3696-3705.
Crossref
Yun Dai, Liang Qiao, Kwok Wah Chan, Mo Yang, Jieyu Ye, Rongxin Zhang, Juan Ma, Bing Zou, Colin S.C. Lam, Jide Wang, Roberta Pang, Victoria P.Y. Tan, H.Y. Lan & Benjamin C.Y. Wong. (2009) Adenovirus-mediated down-regulation of X-linked inhibitor of apoptosis protein inhibits colon cancer. Molecular Cancer Therapeutics 8:9, pages 2762-2770.
Crossref
J J Cody & J T Douglas. (2009) Armed replicating adenoviruses for cancer virotherapy. Cancer Gene Therapy 16:6, pages 473-488.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.